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Abstract
A hallmark of cancer cells is the metabolic switch from oxidative phosphorylation (OXPHOS) to 
glycolysis, a phenomenon referred to as the ‘Warburg effect’, which is also observed in primed 
human pluripotent stem cells (hPSCs). Here, we report that downregulation of SIRT2 and 
upregulation of SIRT1 is a molecular signature of primed hPSCs and that SIRT2 critically 
regulates metabolic reprogramming during induced pluripotency by targeting glycolytic enzymes 
including aldolase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, and 
enolase. Remarkably, knockdown of SIRT2 in human fibroblasts resulted in significantly 
decreased OXPHOS and increased glycolysis. In addition, we found that miR-200c-5p specifically 
targets SIRT2, downregulating its expression. Furthermore, SIRT2 overexpression in hPSCs 
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significantly affected energy metabolism, altering stem cell functions such as pluripotent 
differentiation properties. Taken together, our results identify the miR-200c–SIRT2 axis as a key 
regulator of metabolic reprogramming (Warburg-like effect), via regulation of glycolytic enzymes, 
during human induced pluripotency and pluripotent stem cell function.
In the early twentieth century, Otto Warburg observed a metabolic switch in transformed 
cells compared to normal cells from OXPHOS to glycolysis, even in the presence of high 
levels of oxygen1,2. Interestingly, recent studies showed that the metabolism of different 
types of stem cells, in particular primed pluripotent stem cells (for example, human 
embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs)), is also 
biased towards glycolysis rather than OXPHOS, exhibiting a Warburg-like effect3–7. Indeed, 
more recent studies showed that this metabolic switch from OXPHOS to glycolysis is 
critical for bioenergetics, biosynthetic capacity, and epigenetic regulation in hPSCs8–12, 
which was further supported by metabolomics analyses11,13. Unlike hESCs and hiPSCs that 
represent a primed state, mouse ESCs are known to be at a naive state and energetically 
bivalent, and can dynamically switch from glycolysis to OXPHOS on demand9. Thus, these 
studies suggest that metabolic reprogramming is intimately linked to stem cell identity 
during induced pluripotency. However, at present, the molecular mechanism underlying 
metabolic reprogramming is poorly understood.
Recent proteomics studies revealed that numerous proteins of the nucleus, cytoplasm, and 
mitochondria involved in diverse aspects of cellular metabolism are highly acetylated in 
human, mouse, and prokaryotic cells14–16. In particular, virtually all enzymes involved in 
glycolysis and the tricarboxylic acid cycle were found to be acetylated in human liver 
tissues15, strongly suggesting that protein acetylation is a keymechanism regulating 
metabolism17, which prompted us to hypothesize that protein acetylation regulates, at least 
in part, metabolic reprogramming. Protein acetylation can be modulated by histone acetyl 
transferase (HATs), as well as by class I, II, III, and IV histone deacetylases (HDAC). 
Among these, class IIIHDACs, termed sirtuins, are NAD-dependent protein deacetylases 
that are highly conserved from bacteria to humans18,19. Since sirtuins are the only HDACs 
whose activity is dependent on NAD, a critical cofactor of cell metabolism, we further 
hypothesized that certain sirtuin members play important roles in regulating metabolic 
reprogramming.
Here, we report that altered acetylation levels of glycolytic enzymes by SIRT2 
downregulation critically regulate metabolic reprogramming during human induced 
pluripotency and influence stem cell function and regulation in primed hPSCs.
RESULTS
Warburg-like effect in hPSCs
To compare energy metabolism between hPSCs and their somatic counterpart, we derived 
hiPSCs from human dermal fibroblasts (hDFs) by introducing four reprogramming genes (c-
Myc, Oct4, Sox2, and Klf4) and confirmed pluripotency markers gene expression, almost 
identical morphology, and pluripotent differentiation potential in the resulting hiPSCs and in 
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hESCs (Supplementary Fig. 1a–c). In addition, intracellular ATP levels as well as oxygen 
consumption rate (OCR) were significantly lower in hESCs and hiPSCs compared to hDFs 
(Supplementary Fig. 1d,e). Since the Warburg effect is closely related to increased glucose 
uptake by upregulation of glucose transporters (GLUTs) in cancer cells20, we compared the 
expression levels of GLUT genes. As shown in Supplementary Fig. 1f, GLUT1-4 mRNAs 
were significantly upregulated in both iPSCs and hESCs compared to fibroblasts. Taken 
together, these results, in line with previous findings11,13,21,22, demonstrate that a Warburg-
like effect is operating in primed hPSCs.
Glycolytic enzymes are highly acetylated in hPSCs
To address our hypothesis that acetylation affects the metabolic switch, we compared protein 
acetylation in hESCs and hDFs by liquid chromatography-tandem mass spectrometry (LC-
MS/MS) analyses following immunoprecipitation with acetyl-Lys antibody (Supplementary 
Fig. 1g). This proteomic analysis identified more than 200 acetylated proteins in both hDFs 
and hESCs. To minimize non-specificity, we excluded proteins with fewer than 10 peptide 
hits (black dots, Fig. 1a). The graph in Fig. 1a illustrates this proteomic analysis where 
proteins with higher acetylation (>1.5 fold) in hESCs (red dots) or in hDFs (blue dots) are 
shown. We found that a total of 28 and 15 proteins are hyper- and hypo-acetylated in hESCs 
compared to hDFs, respectively (Supplementary Tables 1 and 2). In agreement with these 
results, western blot analyses confirmed that hESCs and hiPSCs contain higher levels of 
acetylated α-tubulin, well-characterized SIRT2 substrate23, than hDFs, whereas they express 
similar levels of total α-tubulin (Fig. 1a, inset). Notably, this analysis revealed that 5 out of 
10 glycolytic enzymes are hyperacetylated in hESCs: aldolase (encoded by ALDOA), 
glyceraldehyde-3-phosphate dehydrogenase (encoded by GAPDH), phosphoglycerate kinase 
(encoded by PGK1), enolase (encoded by ENO1), and pyruvate kinases (encoded by PKM1 
and 2) (highlighted in red; Supplementary Table 1). Collision-induced dissociation (CID) 
spectra of the acetylated peptides derived from these glycolytic proteins are shown in 
Supplementary Fig. 2.
Downregulation of SIRT2 and upregulation of SIRT1 is a molecular signature of primed 
hPSCs
We next investigated if any acetylation-modulating factor(s) such as HATs or HDACs show 
a unique expression pattern in hPSCs compared to their counterpart somatic tissues by 
means of web-based meta-analyses. We analysed five independent studies of hPSCs against 
various sets of differentiated cell types (GSE28633; ref. 24, GSE18265; ref. 25, GSE20013; 
ref. 26, GSE39144 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39144), and 
GSE9709; ref. 27) using GEO2R (https://www.ncbi.nlm.nih.gov/geo/geo2r)28. We first 
searched if the expression of any acetyl transferase is consistently altered in hPSCs, but 
failed to find any in all five meta-analysis studies (Supplementary Table 3). We next 
analysed all known deacetylases; 11 HDACs (belonging to HDAC I, II, and IV) and 7 SIRTs 
(belonging to HDAC III). Remarkably, we found that SIRT2 is uniquely and consistently 
downregulated in all five independent meta-analyses (Supplementary Fig. 3a and 
Supplementary Table 4). In addition, SIRT1 is upregulated in hPSCs in four meta-analyses. 
In agreement with this, using another web-based database analysis tool (http://
www.nextbio.com), we found that SIRT2 is significantly downregulated whereas SIRT1 is 
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significantly upregulated in hESCs lines compared to human somatic cells (Fig. 1b and 
Supplementary Table 5), while expression levels of other sirtuins (SIRT3-7) were variable 
(Supplementary Fig. 3b–f). These findings prompted us to hypothesize that altered 
acetylation of metabolic enzymes by SIRT1 and/or SIRT2 plays a critical role(s) in 
metabolic reprogramming. To test this, we examined their gene expression during induced 
pluripotency and in vitro differentiation. As shown in Fig. 1c,d, SIRT1 and SIRT2 
expression (both mRNA and protein level) were prominently up- and downregulated in 
hPSCs compared to hDFs, respectively, showing that induced pluripotency accompanies 
SIRT1 induction and SIRT2 suppression. In contrast, during spontaneous differentiation, 
SIRT2 was highly upregulated whereas SIRT1 was downregulated along with pluripotency 
markers Oct4 and Sox2 (Fig. 1e). In addition, SIRT2 was robustly upregulated during 
differentiation of hESCs into midbrain dopamine neurons (Fig. 1g,i), as evidenced by 
dramatic increases in expression of Tuj1, tyrosine hydroxylase (TH), and Lmx1b (Fig. 1f,g), 
which was accompanied by a robust decrease in the expression of SIRT1, Oct4 and Nanog 
(Fig. 1h,i). Our results are in agreement with previous studies showing downregulation of 
SIRT1 during hESC differentiation29,30 and upregulation of SIRT2 during mouse ESC 
differentiation31.
Functional effects and targets of SIRT2
Because glycolytic enzymes including aldolase, GAPDH, PGK1, enolase, and pyruvate 
kinases are highly acetylated and the deacetylase SIRT2 is robustly downregulated in 
hESCs, we hypothesized that SIRT2 downregulation is responsible for their 
hyperacetylation, directly contributing to the Warburg-like effect. To address this, we 
generated stable hESC lines in which expression of SIRT2 and EGFP can be induced by 
doxycycline (Dox) (Fig. 2a and Supplementary Fig. 4a). Under our hESC culture condition 
using the chemically defined culture medium (E8) containing TGF-β, Dox-induced SIRT2 
overexpression (OE) did not change expression levels of pluripotent markers (for example, 
Oct4, Nanog, Esrrb, and Rex1) or the morphology of hESCs compared to control cells (Fig. 
2a and Supplementary Fig. 4b,c). Interestingly, forced expression of SIRT2 in TGF-β-free 
hESC culture condition resulted in spontaneous differentiation (Supplementary Fig. 4c), 
which is in line with the Moussaieff et al. study showing that inhibition of glycolysis causes 
a rapid loss of pluripotency in TGF-β-free culture condition12.
We next investigated the effect of altered SIRT2 expression on acetylation and enzymatic 
activities of these glycolytic proteins. Remarkably, forced expression of SIRT2 in hESCs 
prominently deacetylated all four enzymes tested (aldolase, PGK1, enolase, and GAPDH) 
(Fig. 2b,c), whereas expression levels of their total proteins (see Input; Fig. 2b,c) and 
mRNAs (Supplementary Fig. 4d) were unchanged. PKM1 and 2 could not be analysed here 
due to the lack of isoform-specific antibodies. Furthermore, we found that deacetylation of 
glycolytic enzymes by SIRT2OE in hESCs caused a significant decrease of enzymatic 
activities for all three enzymes tested (aldolase, enolase, and GAPDH) although the total 
proteins were unchanged (Fig. 2b–d). SIRT2 bound to aldolase and enolase (Fig. 2e), 
demonstrating a direct interaction between SIRT2 and these enzymes. Next, we investigated 
the effect of SIRT2 knockdown (KD) on glycolytic enzymes in hDFs using specific 
shRNAs. We found that acetylation levels of aldolase, enolase, PGK1 and GAPDH were 
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substantially increased in SIRT2KD hDFs, although the expression levels of their total 
proteins were similar (Fig. 2f). Furthermore, their enzymatic activities were significantly 
increased, demonstrating a direct correlation between their acetylation levels and activities 
(Fig. 2g).
We next sought to identify specific lysine residues and their functional effects using aldolase 
(AldoA) as an example. We found that a total of 6 and 8 Lys residues are highly acetylated 
in mock- and SIRT2KD cells, respectively (Fig. 3a and Supplementary Table 6). 
Interestingly, K111 and K322 are hyperacetylated in SIRT2KD cells, but not in control cells 
(Supplementary Fig. 5a–d and Supplementary Table 6). Acetylated and non-acetylated forms 
of AldoA peptides were well separated and the acetylated form of AldoA was shown to have 
a 42 higher m/z value due to the acetyl groups. According to protein blast searching (http://
blast.ncbi.nlm.nih.gov/Blast.cgi), the K111, but not the K322, residue belongs to the 
catalytic domain/intersubunit interface (Fig. 3b)32. Thus, the K322 residue may represent an 
as-yet-unidentified domain. In addition, sequence alignment of AldoA showed that K111 
and K322 are highly conserved among diverse species (Fig. 3b). To further determine 
whether K111 and/or K322 are critical for regulating AldoA by SIRT2, we mutated each of 
them to glutamine (acetylated mimetic) or arginine (deacetylated mimetic) and examined 
their activity. We found that mutation of K322, but not K111 to Q robustly increased the 
catalytic activity compared to wild type in both hDFs and 293T cells (Fig. 3c and 
Supplementary Fig. 5e). Moreover, SIRT2KD prominently activated wild-type AldoA and 
K111R, but not K322R (Fig. 3d and Supplementary Fig. 5f), demonstrating that K322 
deacetylation by SIRT2 significantly downregulates its activity. Notably, the AldoA structure 
model showed that K322 is exposed to the outside surface of AldoA, suggesting its 
availability to bind to SIRT2 (crystal structure model of human AldoA, Protein Data Bank 
code: 1ALD) (Fig. 3e)33. Taken together, we propose that SIRT2 directly controls the 
acetylation levels and enzymatic activities of glycolytic enzymes and contributes to 
metabolic reprogramming.
SIRT2 expression levels influence metabolism, cell survival, and pluripotent differentiation 
functions of hPSCs
We next tested if altered SIRT2 levels directly influence glycolytic metabolism in hPSCs by 
measuring extracellular acidification rate (ECAR)34. Indeed, Dox-induced SIRT2OE in H9 
hESCs resulted in reduced ECAR and increased OCR levels, compared to control cells (Fig. 
4a,b and Supplementary Fig. 6g). The same pattern was observed with H7 hESCs and two 
independent iPSC lines (for example, hiPSC-1 and hiPSC-2) (Supplementary Fig. 6a–g). 
Interestingly, the proliferation rate of SIRT2OE hPSCs was significantly reduced compared 
to control cells (Fig. 4c and Supplementary Fig. 6h). We next performed a fluorescence-
based competition assay35,36. When wild-type H9 hESCs (WT) were mixed at a ratio of 1:1 
with GFP-overexpressing H9 cells (GFP), the ratios of GFP+/total cells remained 50% up to 
five passages. In contrast, when WT cells were mixed with SIRT2-GFP-overexpressing H9 
cells (SIRT2), the ratio of GFP+/total cells progressively decreased (Fig. 4d). Since this 
compromised proliferation/self-renewal capacity can be caused by altered self-renewal per 
se, cellular senescence or cell death, we next examined the cell population for the presence 
of the earliest marker of apoptosis, Annexin V. Interestingly, we found that SIRT2OE 
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significantly increased the apoptotic cell population in all four hPSC lines tested (Fig. 4e,f). 
In addition, we found that intracellular levels of reactive oxygen species (ROS) were 
increased by SIRT2OE (Fig. 4g). Furthermore, SIRT2-induced cell death was rescued by 
pretreatment with N-acetyl-L-cysteine (NAC), a potent ROS scavenger (Fig. 4h), strongly 
suggesting that induced SIRT2 levels can cause ROS-dependent apoptotic cell death, leading 
to compromised proliferation/self-renewal capacity.
Next, we investigated the effect of SIRT2OE on metabolic reprogramming during the early 
stage of differentiation. We examined mRNA expression patterns for pluripotency and 
lineage-specific early markers, and measured production of extracellular lactate, a key 
metabolite of glycolysis. As shown in Fig. 5a–c, SIRT2 expression was prominently 
upregulated within two days of differentiation along with early-differentiation markers 
including Pax6, Brachyury (B-T), and Sox17. Furthermore, ECAR levels were decreased as 
early as three days, while lactate production was significantly reduced at day 4 during in 
vitro differentiation (Fig. 5d,e). Remarkably, we found that Dox-induced SIRT2OE in H9 
hESCs and hiPSC-1 during in vitro differentiation resulted in a significant reduction of 
ECAR and extracellular lactate production compared to control cells (Fig. 5d,e and 
Supplementary Fig. 7a–e). To further determine whether SIRT2 expression levels affect the 
pluripotent differentiation potential of hESCs, we examined expression patterns for various 
lineage markers at day 0, 3, 6, 9 or 12 (D0-D12) during spontaneous in vitro differentiation. 
Strikingly, SIRT2OE hESCs with Dox differentiated more efficiently than WT and 
SIRT2OE without Dox to all three germ layer lineages, as evidenced by staining with 
antibodies against ectodermal, endodermal, and mesodermal markers (Fig. 5f). Furthermore, 
expression levels of diverse lineage marker genes of all three germ layers were markedly 
increased in all four SIRT2OE hPSC lines with Dox compared to WT and SIRT2OE without 
Dox at all time points tested (D3-D12) (Fig. 5g and Supplementary Fig. 7f). Taken together, 
our results suggest that SIRT2 levels directly influence energy metabolism and regulate 
survival and pluripotent differentiation potential of hPSCs.
Expression levels of SIRT2 regulate energy metabolism in hDFs and influence the 
reprogramming process
We next addressed if proper regulation of SIRT2 expression is critical for induced 
pluripotency via regulating metabolic reprogramming. To this end, we determined whether 
altered SIRT2 expression induces a metabolic switch in fibroblasts. Indeed, SIRT2KD in 
fibroblasts resulted in significant metabolic changes, including decreased OCR and 
increased ECAR compared to control cells (Fig. 6a,b). Furthermore, compared to control, 
SIRT2KD cells showed significantly decreased OXPHOS capacity, as evidenced by 
decreases in basal respiration, ATP turnover, maximum respiration, and oxidative reserve, as 
well as OCR decrease after FCCP treatment (Fig. 6c–e). We next treated hDFs with 
reprogramming factors together with SIRT2KD. Notably, reprogramming cells with 
SIRT2KD showed significantly reduced oxidative metabolism at both day 3 and day 8, 
compared to control reprogramming cells (Fig. 6f–k). We also examined the dynamics of 
metabolic change by altered SIRT2 expression during the reprogramming process. As shown 
in Fig. 7a, 6 days post-transfection of Y4, SIRT2 expression was prominently 
downregulated. Furthermore, decreased OCR and increased ECAR levels were also 
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observed as early as 6 days post-transfection, while lactate production was significantly 
induced at day 9 posttransfection (Fig. 7b–d). Importantly, we found that reprogramming 
cells with SIRT2KD resulted in significantly enhanced changes in OCR and ECAR levels 
and induction of extracellular lactate production compared to control reprogramming cells 
(Fig. 7a–d).
We next tested whether altered SIRT2 expression influences iPSC generation from 
fibroblasts. Indeed, SIRT2OE in hDFs interfered with iPSC generation by approximately 
80% while SIRT2KD significantly increased the efficiency (Fig. 7e,f), suggesting that 
downregulation of SIRT2 is critical for iPSC generation, via enhancing metabolic 
reprogramming. In addition, SIRT1KD prominently reduced iPSC generation whereas its 
overexpression significantly enhanced it (Supplementary Fig. 8e,f), which is in agreement 
with previous studies30,37. However, SIRT1OE with or without reprogramming factors in 
hDFs did not influence oxidative metabolism at day 3 (Supplementary Fig. 8b–d,g). Notably, 
SIRT1OE appears to enhance metabolic switch at day 6 (Supplementary Fig. 8h), which is 
likely due to an indirect effect by enhancing the reprogramming process (Supplementary 
Fig. 8e,f). To further test whether enhanced reprogramming by SIRT2KD depends on 
elevated glycolysis, we next tested the effects of 2-deoxy-glucose (2DG), a general inhibitor 
of glycolysis, on metabolic changes and iPSC generation. Notably, treatment with 0.2 mM 
2DG decreased the glycolytic flux in Y4+SIRT2KD to the level of Y4 only without 2DG 
(Fig. 7h), resulting in the generation of iPSC-like colonies to the level of Y4 only without 
2DG (Fig. 7i). In addition, when fibroblasts were treated with 0.5mM 2DG, metabolic 
changes and increased generation of iPSC-like colonies by SIRT2KD were abrogated (Fig. 
7g–i). When fibroblasts were treated with 1mM or higher concentrations of 2DG, the 
generation of iPSC-like colonies was completely blocked. Taken together, these results 
strongly suggest that enhanced reprogramming by SIRT2KD is linked to the effect of SIRT2 
effect on metabolic reprogramming.
miR-200c suppresses SIRT2 expression
To address whether SIRT2 might be regulated by a specific miRNA(s), we performed 
miRNA target-prediction analyses using Rna22 (ref. 38) and identified 656 potential 
miRNAs that can target the SIRT2 gene. Among these, we further identified four hPSC-
enriched miRNAs (that is, miR-25, -92b, -200c, and -367) (ref. 39) and their potential target 
sites (miRNA-response elements; MREs) in the 5′-untranslated region and coding region of 
SIRT2 (Supplementary Table 7). Interestingly, we found that miR-200c, known to be 
induced by Oct4 (ref. 40), prominently downregulates SIRT2 expression at both the mRNA 
and protein levels (Fig. 8a,b). Because our prediction analysis showed that SIRT2 could be 
targeted by miR-200c-5p but not miR-200c-3p (Fig. 8c and Supplementary Table 7), we 
determined the effect of each precursor miRNA oligomer on SIRT2 expression. Indeed, pre-
miR-200c-5p, but not pre-miR-200c-3p or scrambled oligomers (Scr), significantly 
decreased the expression level of SIRT2 mRNA or protein (Fig. 8d,e). We also found that 
pre-miR-200c-5p, but not pre-miR-200c-3p or scrambled sequences, significantly decreased 
the luciferase reporter expression of both identified MREs (Fig. 8f), indicating that 
miR-200c-5p downregulates SIRT2 expression by targeting these two MREs. Taken 
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together, our results support a model in which miR-200c-5p suppresses SIRT2 expression, 
leading to metabolic reprogramming during human induced pluripotency (Fig. 8g).
DISCUSSION
Here, we uncovered a molecular signature consisting of SIRT2 downregulation and SIRT1 
upregulation in primed hPSCs during the reprogramming process, which is critical for 
induced pluripotency. We found that SIRT2KD in human fibroblasts significantly increases 
hiPSC generation while SIRT2OE prominently inhibits it. Regulation of SIRT1 expression is 
also critical for induced pluripotency but in the opposite direction: SIRT1OE significantly 
increases hiPSC generation whereas SIRT1KD robustly interferes with it. In line with their 
opposite direction of expression, it appears that SIRT1 and SIRT2 regulate induced 
pluripotency through distinct mechanisms and targets. For instance, our results highlight that 
acetylation levels and activities of glycolytic enzymes (for example, aldolase, PGK1, 
enolase, and GAPDH) are robustly regulated by SIRT2, but not SIRT1. In agreement with 
our results, previous studies showed upregulation of SIRT1 in hPSCs29,30 and SIRT1’s 
important roles for generation of mouse iPSCs30,37. In addition, the study by Si et al.31 
showed that SIRT2 is upregulated during in vitro differentiation of mouse ESCs and 
SIRT2KD promotes mesoderm and endoderm lineages while compromising ectoderm 
differentiation. In contrast, our results show that SIRT2 regulates more fundamental stem 
cell functions such as metabolism, cell survival/death, and pluripotent differentiation 
potential in hPSCs. The different functional role(s) of SIRT2 between these two studies 
possibly reflect species differences (mouse versus human). Another possibility is that SIRT2 
has distinct functional role(s) for different stem cell state. Unlike primed hPSCs, mouse 
ESCs are at a naive pluripotent state and energetically bivalent9. Thus, further investigations 
are needed to determine whether SIRT2 (and/or SIRT1) distinctively regulate stem cell 
function in naive and primed pluripotent stem cells.
Importantly, we found multiple lines of evidence strongly suggesting that SIRT2 is a key 
regulator of metabolic reprogramming (Warburg-like effect) during human induced 
pluripotency, and critically regulates stem cell functions. Firstly, SIRT2OE in hESCs 
robustly altered acetylation and enzymatic activities of glycolytic enzymes, significantly 
compromising glycolytic metabolism. Secondly, SIRT2OE in hPSCs caused enhanced 
OXPHOS and reduced glycolysis, leading to significantly reduced cell proliferation, at least 
in part, by increased apoptotic cell death via enhanced production of ROS. In addition, 
SIRT2OE in hPSCs leads to enhanced pluripotent differentiation potential that is 
accompanied by a further reduction of lactate production. Thirdly, SIRT2KD in human 
fibroblasts robustly increased acetylation levels and activities of glycolytic enzymes, leading 
to prominent metabolic switch from OXPHOS to glycolytic metabolism. Fourthly, 
SIRT2KD together with the introduction of reprogramming factors into human fibroblasts 
more rapidly and effectively induced metabolic switch compared to reprogramming factors 
alone, resulting in more efficient hiPSC generation. In contrast, altered expression of SIRT1 
did not directly influence the metabolic status, further supporting that SIRT1 and SIRT2 
regulate the reprogramming process via distinct mechanisms. Taken together, our data 
indicate that altered levels of SIRT2 during induced pluripotency and differentiation regulate 
OXPHOS and glycolysis in opposite directions, thus facilitating the metabolic switches. 
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While SIRT2’s regulation of glycolysis appears to be linked to acetylation levels of 
glycolytic enzymes and their activities, at present it is unknown how OXPHOS is regulated. 
Although it is possible that SIRT2 regulates OXPHOS through PGC1α, a master regulator 
of mitochondrial biogenesis41, its precise regulatory mechanism(s) await further 
investigation. Notably, SIRT2 is the only sirtuin residing primarily in the cytoplasm18,19, and 
this may provide a unique advantage to directly control metabolic reprogramming by 
regulating glycolytic enzymes which also reside in the cytoplasm.
Our finding that there is a direct correlation between acetylation levels and enzymatic 
activities is surprising because it was suggested that acetylation is inhibitory to the activities 
of most enzymes42. For instance, a glycolytic enzyme, phosphoglycerate mutase, was 
reported to be stimulated through deacetylation by SIRT2 (ref. 43). However, other studies 
showed that the same enzyme’s activity is downregulated by SIRT1 or SIRT2 (refs 44,45). 
In addition, a recent study showed that GAPDH is activated by acetylation of its K254 
residue46. Furthermore, increasing GapA acetylation in Salmonella by Pat acetylase 
treatment increased its glycolysis activity16. Thus, the functional effect of acetylation 
appears to be enzyme- and perhaps lysine-specific. To further validate our findings, we 
performed LC-MS/MS analyses of aldolase A. We identified K111 and K322 as specific 
SIRT2 target sites and found that deacetylation of K322 by SIRT2 critically inhibits the 
enzyme activity of aldolase A. K322 resides on an outside surface with unknown functional 
domain, and our functional data will provide useful insights into this important enzyme and 
its regulation in diseases such as cancer.
Finally, we found that SIRT2 is suppressed by miR-200c, a miRNA induced in pluripotent 
stem cells by Oct4 (ref. 40), via binding sites in the sirtuin gene coding sequence. This 
miRNA enhances metabolic reprogramming via SIRT2 suppression and this appears to be a 
critical step of induced pluripotency (Fig. 8g). Indeed, enforced SIRT2OE is highly 
inhibitory to iPSC reprogramming in human cells. It should be of interest to determine 
whether this regulation of metabolism by the miR-200c–SIRT2 axis is also important for 
other types of stem cells (for example, adult stem cells, naive pluripotent stem cells, and 
cancer stem cells). A defect in this pathway could lead to abnormal stem cell functions and 
compromised development in embryos or dysfunctional tissues in adults. Further, 
manipulation of the metabolic control of cell fate and function via the miR-200c–SIRT2 axis 
may aid translational approaches that use stem cells for regenerative medicine and cell 
replacement therapy.
METHODS
Cell culture
Human BJ dermal fibroblasts (hDF) and HEK293T cells were purchased from ATCC and 
grown in Dulbecco’s modified Minimal Essential Medium (DMEM) supplemented with 
2mM L-glutamine, 10% fetal bovine serum (FBS), 100Uml−1 penicillin and 100 μgml−1 
streptomycin (all from Invitrogen). For iPSC induction, DMEM/F-12 medium supplemented 
with 2mM L-glutamine, 1mM β-mercaptoethanol, 1x non-essential amino acids (NEAA), 
20% knockout serum replacement (KSR), 100Uml−1 penicillin, 100 μgml−1 streptomycin 
and 10 ngml−1 basic fibroblast growth factor (bFGF; all from Invitrogen) was used as the 
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reprogramming medium. Two hESC lines (H7(WA-07) and H9(WA-09)) and hiPSC line 
iPS-DF19-9-11T (iPS DF19-9-11T. H; termed hiPSC-2) were obtained from WiCell 
Institute. All hPSC lines were maintained in Essential 8 medium (Invitrogen) using Matrigel 
Matrix (Corning Life Sciences) and passaged using 0.5mM EDTA (Invitrogen) for gentle 
dissociation. No cell lines used in this study were found in the database of commonly 
misidentified cell lines that is maintained by ICLAC and NCBI Biosample. All cell lines 
were authenticated by Interspecies Determination (Isoenzyme Analysis and STR analysis) 
by the providing company and were routinely tested for mycoplasma detection using a 
Venor GeM Mycoplasma Detection Kit (Sigma-Aldrich).
Plasmid construction and lentivirus production
Human SIRT1 and SIRT2 coding sequences were PCR-amplified from hESCs (H9) and 
hDFs, respectively, then cloned into the pGEM-T Easy vector (Promega). The 2A sequence 
of the Thoseaasigna virus (T2A)-linked EGFP was amplified from plasmid pCXLE-EGFP 
(#27082; Addgene) by RT-PCR and cloned into the pGEM-T Easy vector. The SIRT1 and 
SIRT2 fragments were then cut off from the corresponding vectors and inserted into the 
pGEM-T-T2A-EGFP to generate pGEM-T-SIRT1-T2A-EGFP and pGEM-T-SIRT2-T2A-
EGFP, respectively. The identity of the SIRT1-T2A-EGFP and SIRT2-T2A-EGFP constructs 
was confirmed by sequencing. Subsequently, they were introduced into the EcoRI site of the 
FUW-tetO vector (Addgene). Human AldoA-Myc constructs, the AldoA fragment was PCR-
amplified from H9 hESCs, and then cloned into the pcDNA3.1-Myc/His vector (Invitrogen). 
For the psicheck-2 constructs, the CDS fragments were cloned downstream of the Renilla 
luciferase open reading frame. AldoA point mutations were generated by site-directed 
mutagenesis using a QuickChange II XL Site-Directed Mutagenesis kit (Agilent 
Technologies).
FUW-tetO-based lentiviral vectors containing the other individual reprogramming factors for 
Oct4 (#20726), Sox2 (#20724), Klf4 (#20725) or c-Myc (#20723) were purchased from 
Addgene. The polycistronic human STEMCCA lentiviral vector47 was kindly provided by 
G. Mostoslavsky (Boston University). Genetic knockdown of SIRT1 or SIRT2 was carried 
out using lentiviral shRNA plasmids targeting human SIRT1 (RHS3979-201750186, 
RHS3979-201750188, RHS3979-201750189, and RHS3979-201750190) or human SIRT2 
(RHS3979-201797165, RHS3979-201768981, RHS3979-201768982, RHS3979-201768983, 
RHS3979-201768984, and RHS3979-201768985) that were obtained from GE Healthcare 
Dharmacon.
For lentivirus production, lentiviral vectors were co-transfected with packaging plasmids 
into 293T cells, maintained in DMEM supplemented with 10% FBS, using Lipofectamine 
2000 (Invitrogen) according to the manufacturer’s instruction. Supernatants containing 
lentivirus were harvested 48 h after transfection and filtered using 0.45 μm Millex-HV 
(Millipore) filters to remove cell debris.
Human iPSC induction
Human iPSCs were generated using lentiviral particles from inducible lentiviral vectors or 
STEMCCA vectors to introduce the OSKM factors (Oct4, Sox2, Klf4, and c-Myc) into 
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fibroblasts48. ES-like colonies formed after 3 weeks of viral infection and the observed ES-
like colonies were handpicked and transferred onto mouse feeder cells (MEF)-plated or on 
Matrigel-coated tissue culture plates to generate iPSC lines. iPSC colonies were 
mechanically picked until iPSC lines were established. One of the established iPSC clone 
(termed hiPSC-1) were used for further analyses. Authentication of the hiPSC-1 cell line 
was performed on the basis of pluripotent gene expression.
Web-based meta-analysis
Microarray datasets from five independent studies (GSE28633; ref. 24, GSE18265; ref. 25, 
GSE20013; ref. 26, GSE39144 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE39144), and GSE9709; ref. 27) of hESCs and/or hiPSCs against various sets of 
differentiated cell types (for example, fibroblasts, neurons or endothelial cells) were 
analysed using GEO2R (https://www.ncbi.nlm.nih.gov/geo/geo2r) to identify acetylation-
modulating factor(s) whose expression is significantly different in hPSCs compared to their 
differentiated counterparts28. Of 40,000–50,000 primers, corresponding to mRNA 
transcripts, only the top 20% of mRNA transcripts were selected as a cutoff range to validate 
significance, based on P values. Each gene expression in a given database was further 
monitored across multiple groups of hPSCs to determine gene expression changes.
Live cell metabolic analysis
Oxygen consumption rate (OCR) and extracellular acidification rates (ECAR) were 
measured using the XFp8 or XF24 analyser (Agilent Technologies) according to the 
manufacturer’s instructions. Briefly, cells were plated into wells of an XF cell culture 
microplate and incubated at 37 °C in a CO2 incubator for 24 h to ensure attachment. The 
assay was started after cells were equilibrated for 1 h in XF assay medium supplemented 
with 10mM glucose, 5mM sodium pyruvate and 2mM glutamine in a non-CO2 incubator. 
Mitochondrial activity between hDFs and hESCs/parental hDFs and iPSCs were monitored 
through sequential injections of 1 μM oligomycin, 0.3 μM FCCP and 1 μM rotenone/
antimycin A to calculate basal respiration rates (baseline OCR—rotenone/antimycin A 
OCR), ATP dependent (basal respiration rate—oligomycin OCR), maximum respiration 
(FCCP OCR—rotenone/antimycin A OCR), and oxidative reserve (maximum respiration 
rate—basal respiration rate). Glycolytic processes were measured by serial injections of 
10mM glucose, 1 μM oligomycin, and 100mM 2-deoxyglucose to calculate basal glycolytic 
rate, glycolytic capacity (in response to oligomycin), and glycolytic reserve (glycolytic 
capacity—basal rate). Each plotted value was normalized to total protein quantified using a 
Bradford protein assay (Bio-Rad).
Immunoprecipitation
For immunoprecipitation assays, hESCs and hDFs lysates were incubated with specific 
antibodies against acetyl-Lys (Cell Signaling Technology, catalogue No. 9441, 1:100), 
aldolase (Santa Cruz Technology, catalogue No. sc-12059, 1:100), enolase (Cell Signaling 
Technology, catalogue No. 3810, 1:50), PGK1 (Santa Cruz Technology, catalogue No. 
sc-130335, clone No. 14, 1:100) or GAPDH (Santa Cruz Technology, catalogue No. 
sc-32233, clone No. 6C5, 1:50) at 4 °C overnight. After addition of protein A/G UltraLink 
resin, samples were incubated at 4 °C for 2 h. Beads were washed three times with PBS and 
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proteins were released from the beads by boiling in SDS-sample loading buffer and analysed 
by SDS–PAGE.
Liquid chromatography mass spectrometry (LC-MS/MS)
For identification of acetylated proteins, hESCs or hDFs (control) were grown in 100mm 
dishes up to 60–70% confluence. Cells were collected, washed with PBS and lysed (50mM 
Tris-HCl, pH 7.4, 150mM NaCl, 1mM EDTA, 1mM EGTA, 0.5% NP-40, 1% SDS, and 
protease inhibitor cocktail). Whole cell lysate from hESCs and hDFs were incubated for 10 
min on ice followed by centrifugation at 14,000g for 15 min at 4 °C. Supernatants were 
collected and pellets were discarded. Protein concentrations were determined using the BCA 
assay (Pierce) using bovine serum albumin (BSA) as standard. For immunoprecipitation 
assays, 500 μg of hESC and hDFs lysates were incubated with anti-acetyl-Lys antibody (Cell 
Signaling Technology, catalogue No. 9441, 1:100) at 4 °C for overnight. After addition of 
Protein A/GUltraLink resin, samples were incubated at 4 °C for 2 h. Beads were washed 
three times with PBS and proteins were released from the beads by addition of SDS-sample 
loading buffer. The eluted proteins were analysed by SDS–PAGE and the gel stained with 
Coomassie Blue. For LC-MS/MS analyses, the gel was de-stained and bands cut and 
processed as follows. Briefly, acetylated proteins bands were divided into 10mm sections 
and subjected to in-gel digestion with trypsin. The tryptic digests were separated by online 
reversed-phase chromatography using a Thermo Scientific Eazy nano LC II UHPLC 
equipped with an autosampler using a reversed-phase peptide trap EASY-Column(100 μm 
inner diameter, 2 cm length) and a reversed-phase analytical EASY-Column (75 μm inner 
diameter, 10 cm length, 3 μm particle size), both from Thermo Scientific, followed by 
electrospray ionization using a 30 μm (i.d.) nanobore stainless steel online emitter (Thermo 
Scientific) and a voltage set at 2.6V, at a flow rate of 300 nl min−1. The chromatography 
system was coupled in line with an LTQ-Orbitrap mass spectrometer. Spectra were searched 
against the Human IPI v3.7 DB using the Sorcerer 2 IDA Sequest-based search algorithm, 
and comparative analysis of proteins identified in this study was performed using Scaffold 4. 
LC-MS/MS analysis was performed at the Biopolymers & Proteomics Core Facility of the 
David H. Koch Institute at MIT and at the Medicinal Bioconvergence Research Center at 
Seoul National University. To compare protein acetylation between hESCs and hDFs, we 
quantified the acetylated proteins in both samples based on spectral counts. The spectral 
counts were first normalized to ensure that average spectral counts per protein were the same 
in the two data sets49. A G test was used to judge statistical significance of protein 
abundance differences50. Briefly, the G value of each protein was calculated as follows,
where S1 and S2 are the detected spectral counts of a given protein in any of two samples for 
comparison. Although the theoretical distribution of G values is complex, these values 
approximately fit to the χ2 distribution (1 degree of freedom), allowing the calculation of 
related P values50. For identification of acetylation sites on AldoA, we pulled down Myc-
conjugated AldoA proteins from 293T cells infected with AldoA-Myc-overexpressing 
plasmid together with empty or SIRT2KD plasmid by immunoprecipitation with Myc 
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antibody (Sigma-Aldrich, catalogue No. 11667149001, clone No. 9E10, 1:200). The AldoA-
Myc band was excised, digested with chymotrypsin, and analysed using an LTQ-Orbitrap 
ion-trap mass spectrometer from Thermo Scientific (Taplin Mass Spectrometry Facility, 
Harvard University (https://taplin.med.harvard.edu/home)).
Western blot analysis
Samples (50 μg) were loaded onto a 12% SDS–PAGE and separated by electrophoresis 
followed by transfer onto a piece of Immun-Blot PVDF membrane (Bio-Rad). After transfer, 
the membrane was blocked at room temperature with Tris-buffered saline (TBS) containing 
0.1% Tween-20 and 5% (w/v) skim milk for 3–5 h and then incubated overnight at 4 °C with 
primary antibody. The membrane was washed three times with TBS containing 0.05% 
Tween-20 (TBST) and then incubated for 2 h with horseradish peroxidase (HRP)-conjugated 
goat anti-mouse IgG (Santa Cruz Biotechnology, 1:1,000) or goat anti-rabbit IgG 
(Invitrogen, 1:3,000). After washing twice with TBST and once with TBS, bound antibodies 
were detected by chemiluminescence using the SuperSignal West Pico kit (Pierce). 
Antibodies against acetyl-Lys (Catalogue No. 9441, 1:1,000) and Enolase (Catalogue No. 
3810, 1:1,000) were purchased from Cell Signaling Technology, β-actin (Catalogue No. 
ab8227, 1:1,000), α-tubulin (Catalogue No. ab4074, 1:1,000), acetylated-α-tubulin 
(Catalogue No. ab24610, clone No. 6-11B-1, 1:1,000), SIRT1 (Catalogue No. ab32441, 
clone No. E104, 1:1,000), and SIRT2 (Catalogue No. ab51023, clone No. EP1668Y, 
1:1,000) from Abcam, Aldolase A (Catalogue No. sc-12059, 1:1,000), PGK1 (Catalogue 
No. sc-130335, clone No. 14, 1:1,000), GAPDH (Catalogue No. sc-32233, clone No. 6C5, 
1:1,000) from Santa Cruz Biotechnology. We used HRP-conjugated Veriblot for IP 
secondary antibody (Abcam, catalogue No. ab131366, 1:500) to facilitate detection of 
immunoprecipitated proteins without co-detecting the IgG heavy and light chains. The 
PVDF membrane was stripped by washing three times with TBST followed by incubation at 
50 °C for 30 min with shaking in stripping buffer (62.5mM Tris-HCl, pH 6.7, 100mM β-
mercaptoethanol, and 2% SDS). After incubation, the membrane was washed several times 
with TBST. Stripped membranes were blocked and probed with primary and secondary 
antibodies as previously described.
Immunofluorescence
For immunofluorescence assays, cells were immediately fixed (2% formaldehyde, 100mM 
KCl, 200mM sucrose, 1mM EGTA, 1mM MgCl2, 10mM PIPES, pH 6.8) for 10 min, 
washed with PBS and then treated with permeabilization buffer (0.2% Triton X-100, 100mM 
KCl, 200mM sucrose, 1mM EGTA, 1mM MgCl2, 10mM PIPES, pH 6.8) for 10 min. Cells 
were washed with PBS three times and incubated with blocking solution containing 3% 
BSA in PBS for 15 min. Cells were washed with PBS three times and incubated with 
primary antibodies in blocking solution at 4 °C overnight. Oct4 (Catalogue No. sc-5279, 
clone No. C-10, 1:500) and Nanog (Catalogue No. sc-33759, 1:500) antibodies were 
obtained from Santa Cruz Biotechnologies, SSEA4 (Catalogue No. MAB4304, clone No. 
MC-813-70, 1:500), TRA-1-60 (Catalogue No. MAB4360, clone No. TRA-1-60, 1:500) and 
Tyrosine hydroxylase (TH, catalogue No. AB1542, 1:1,000) antibodies from EMD 
Millipore, Otx2 (Catalogue No. AF1979, 1:500), Sox17 (Catalogue No. AF1924, 1:500) and 
Brachyury (Catalogue No. AF2085, 1:500) antibodies from R&D Systems, class III β-
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tubulin (Tuj1, catalogue No. MMS-435P, clone No. TUJ1, 1:500) antibody from Covance. 
Cells were washed with PBS three times and incubated with goat anti-mouse Alexa 488, 
donkey anti-rabbit Alexa 568 or donkey anti-sheep Alexa 568 (Invitrogen, 1:300) in 
blocking solution. After washing with PBS, nuclei were stained with Hoechst33342 
(Invitrogen). Each image was examined using a confocal laser-scanning microscope 
(Olympus America).
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
Total RNA was extracted from cells by using the Direct-zol RNA purification Kit (Zymo 
Research) and cDNA was synthesized using the ThermoScript RT-PCR system (Invitrogen). 
For quantitative analyses, qRT-PCR (Bio-Rad) were performed using SsoAdvanced SYBR 
Green supermix (Bio-Rad) with target genes specific primers. The expression level of each 
gene is shown as a relative value following normalization against that of the β-actin gene. 
Primers used in this study are listed in Supplementary Table 8.
ATP determination assay
Cellular ATP concentration was measured using an ATP determination kit (Molecular 
Probe). Cells (iPSCs and parental hDFs/hESCs and hDFs) were washed three times with 
PBS and lysed by addition of water and boiled for 5 min. Cell lysates were collected by 
centrifugation for 15 min at 4 °C. ATP chemiluminescent detection was performed using 
firefly luciferase and luciferin and measured by a SpectraMax L (Molecular Devices). Cell 
lysates protein concentrations were determined using the Bradford assay (Bio-Rad) and 
relative luminescent units were normalized according to protein concentrations.
Neuronal and spontaneous differentiation
Neuronal differentiation was performed as described previously with slight modifications51. 
Briefly, hESCs were dissociated and plated on bacterial dishes in hESC medium without 
bFGF for 1 week to allow formation of embryoid bodies (EB). EBs were allowed to attach to 
tissue culture dish and neuronal precursors were selected by incubation in DMEM/F-12 
medium supplemented with 2mM L-glutamine, Insulin-Transferrin-Selenium-G 
(Invitrogen), and fibronectin (Sigma-Aldrich) for 30 days. hESCs and hiPSCs in vitro 
spontaneous differentiations were performed by culturing in serum-free ITSFn medium for 
different periods of time up to 12 days without EB formation.
Fluorescence-based competition assay
Fluorescence-based competition assay was performed as described previously with slight 
modifications37,38. Briefly, GFP expressing hESCs (GFP) or SIRT2 (and GFP)-inducible 
hESCs (SIRT2) were mixed with wild-type hESCs (GFP−) and cultured in Matrigel-coated 
6-well plates. Every five days (one passage) cells were dissociated using accutase (Sigma-
Aldrich) and replated. At each passage, the proportion of GFP+/GFP− cells was measured by 
flow cytometry on a BD Accuri flow cytometer using the Accuri C6 data analysis software. 
Analyses were carried out for six consecutive passages.
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Enzyme activity assay
Enzyme activity of aldolase, enolase, and GAPDH was measured using an enzymatic 
colorimetric assay kit (All from Biovision) according to the manufacturer’s instructions.
Proliferation assay
Cells were detached using accutase for 10 min and suspended in ESC medium and counted 
using a haemocytometer. An equal number of cells (1 × 104 cells/well) were seeded on 
Matrigel-coated 12-well plates. The total number of cells per well was determined at 2, 4, 6 
days post-seeding using a haemocytometer.
Annexin V staining
For apoptosis analysis, cells were washed twice with cold PBS, and then stained with 
Annexin V-PE and 7-AAD (559763; BD Biosciences), and analysed by flow cytometer.
Luciferase reporter assay
We used the Promega dual luciferase assay kit to perform the luciferase assay according to 
the manufacturer’s instructions. In brief, cell lysates were analysed for luciferase activity 
using the dual luciferase system and two luciferase enzymes, one (from Renilla reniformis) 
containing the experimental target sequence and another (from firefly) containing the 
control. The Renilla/firefly luciferase ratios were normalized against the empty psicheck-2 
vector and averaged over six replicates.
Cellular ROS measurements
Intracellular ROS levels were determined using a CellROX Deep Red Oxidative Stress 
Reagent (C10422; Life technologies) according to the manufacturer’s instructions.
Lactate assay
Extracellular lactate production was measured using L-Lactate assay kit (700510; Cayman 
Chemical) according to the manufacturer’s instructions.
Statistics and reproducibility
Data were analysed using GraphPad Prism 5.0.1 software (GraphPad Software) and are 
presented as mean with s.e.m. or s.d. (as indicated in figure legends). Statistic tests were 
performed and P value thresholds were obtained using GraphPad 5.0.1. Multiple groups 
were tested using analysis of variance (ANOVA) and comparisons between two groups were 
performed using two-tailed unpaired Student’s t-test. Statistically significant differences are 
indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001. Representative 
figures are shown in Figs 1a,d,f,i, 2a–c,e,f, 3a, 4e, 5f, 7e,f,i and 8b,e and Supplementary Figs 
1a–d,g, 4c and 8e,f. Each experiment was repeated independently: 2 repeats (Figs 1e and 5g 
and Supplementary Fig. 7f), 3 repeats (Figs 1a,c,d,f–i, 2, 3a,c,d, 4a–f,h, 5, 6, 7d–f,i and 
8a,b,d–f and Supplementary Figs 1a–d,f,g, 4, 5e,f, 6, 7a–e and 8b–h), 4 repeats (Fig. 7a–
c,g,h and Supplementary Fig. 1e), 5 repeats (Fig. 4g).
Cha et al. Page 15
Nat Cell Biol. Author manuscript; available in PMC 2017 August 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Data availability
Previously published data sets are available under accession numbers GSE28633, 
GSE18265, GSE20013, GSE39144, and GSE9709. LC-MS/MS results used in this study 
have been provided in Supplementary Tables 1 and 2. All raw mass spectrometry proteomics 
data reported in this study have been deposited to the ProteomeXchange Consortium via the 
PRIDE partner repository with the data set identifier PXD006036. Source data for Figs 
1c,e,g,h, 2d,g, 3c,d, 4a–d,f–h, 5a–e,g, 6a–k, 7a–i and 8a,d,f, and Supplementary Figs 1d–f, 
4b,d, 5e,f, 6a–h, 7a–f and 8b–h have been provided in Supplementary Table 9. Unprocessed 
western blots, including two repeat experiments for each blot, have been provided for Figs 
1a,d,i, 2b,c,e,f, 3a and 8b,e, and Supplementary Fig. 1d,g in Supplementary Fig. 9. All other 
data supporting the findings of this study are available from the corresponding author upon 
request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This work was supported by NIH grants (NS084869, NS070577, and GM101420) and the National Research 
Foundation of Korea (2011-0030043). The authors are grateful to members of the Kim laboratory for critical 
discussions.
References
1. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927; 
8:519–530. [PubMed: 19872213] 
2. Warburg O. On the origin of cancer cells. Science. 1956; 123:309–314. [PubMed: 13298683] 
3. Rafalski VA, Mancini E, Brunet A. Energy metabolism and energy-sensing pathways in mammalian 
embryonic and adult stem cell fate. J Cell Sci. 2012; 125:5597–5608. [PubMed: 23420198] 
4. Ito K, Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol 
Cell Biol. 2014; 15:243–256. [PubMed: 24651542] 
5. Burgess RJ, Agathocleous M, Morrison SJ. Metabolic regulation of stem cell function. J Intern Med. 
2014; 276:12–24. [PubMed: 24697828] 
6. Zhang J, Nuebel E, Daley GQ, Koehler CM, Teitell MA. Metabolic regulation in pluripotent stem 
cells during reprogramming and self-renewal. Cell Stem Cell. 2012; 11:589–595. [PubMed: 
23122286] 
7. Folmes CD, Dzeja PP, Nelson TJ, Terzic A. Metabolic plasticity in stem cell homeostasis and 
differentiation. Cell Stem Cell. 2012; 11:596–606. [PubMed: 23122287] 
8. Zhang J, et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent 
stem cells. EMBO J. 2011; 30:4860–4873. [PubMed: 22085932] 
9. Zhou W, et al. HIF1α induced switch from bivalent to exclusively glycolytic metabolism during 
ESC-to-EpiSC/hESC transition. EMBO J. 2012; 31:2103–2116. [PubMed: 22446391] 
10. Varum S, et al. Energy metabolism in human pluripotent stem cells and their differentiated 
counterparts. PLoS ONE. 2011; 6:e20914. [PubMed: 21698063] 
11. Folmes CD, et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent 
glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011; 14:264–271. [PubMed: 
21803296] 
12. Moussaieff A, et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the 
early differentiation of embryonic stem cells. Cell Metab. 2015; 21:392–402. [PubMed: 25738455] 
Cha et al. Page 16
Nat Cell Biol. Author manuscript; available in PMC 2017 August 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
13. Panopoulos AD, et al. The metabolome of induced pluripotent stem cells reveals metabolic 
changes occurring in somatic cell reprogramming. Cell Res. 2012; 22:168–177. [PubMed: 
22064701] 
14. Kim SC, et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics 
survey. Mol Cell. 2006; 23:607–618. [PubMed: 16916647] 
15. Zhao S, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010; 
327:1000–1004. [PubMed: 20167786] 
16. Wang Q, et al. Acetylation of metabolic enzymes coordinates carbon source utilization and 
metabolic flux. Science. 2010; 327:1004–1007. [PubMed: 20167787] 
17. Guarente L. The logic linking protein acetylation and metabolism. Cell Metab. 2011; 14:151–153. 
[PubMed: 21803285] 
18. Guarente L, Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med. 2011; 
364:2235–2244. [PubMed: 21651395] 
19. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. 
Nature. 2009; 460:587–591. [PubMed: 19641587] 
20. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004; 
4:891–899. [PubMed: 15516961] 
21. Mathieu J, et al. Hypoxia-inducible factors have distinct and stage-specific roles during 
reprogramming of human cells to pluripotency. Cell Stem Cell. 2014; 14:592–605. [PubMed: 
24656769] 
22. Prigione A, et al. HIF1α modulates cell fate reprogramming through early glycolytic shift and 
upregulation of PDK1-3 and PKM2. Stem Cells. 2014; 32:364–376. [PubMed: 24123565] 
23. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E. The human Sir2 ortholog, SIRT2, is an 
NAD+-dependent tubulin deacetylase. Mol Cell. 2003; 11:437–444. [PubMed: 12620231] 
24. Fathi A, et al. Comprehensive gene expression analysis of human embryonic stem cells during 
differentiation into neural cells. PLoS ONE. 2011; 6:e22856. [PubMed: 21829537] 
25. Assou S, et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a 
web-based expression atlas. Stem Cells. 2007; 25:961–973. [PubMed: 17204602] 
26. Li Z, et al. Functional and transcriptional characterization of human embryonic stem cell-derived 
endothelial cells for treatment of myocardial infarction. PLoS ONE. 2009; 4:e8443. [PubMed: 
20046878] 
27. Masaki H, et al. Heterogeneity of pluripotent marker gene expression in colonies generated in 
human iPS cell induction culture. Stem Cell Res. 2007; 1:105–115. [PubMed: 19383391] 
28. Barrett T, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 
2013; 41:D991–D995. [PubMed: 23193258] 
29. Calvanese V, et al. Sirtuin 1 regulation of developmental genes during differentiation of stem cells. 
Proc Natl Acad Sci USA. 2010; 107:13736–13741. [PubMed: 20631301] 
30. Lee YL, et al. Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse 
embryonic fibroblasts through the miR-34a and p53 pathways. PLoS ONE. 2012; 7:e45633. 
[PubMed: 23029150] 
31. Si X, et al. Activation of GSK3β by Sirt2 is required for early lineage commitment of mouse 
embryonic stem cell. PLoS ONE. 2013; 8:e76699. [PubMed: 24204656] 
32. Marchler-Bauer A, et al. CDD: NCBI’s conserved domain database. Nucleic Acids Res. 2015; 
43:D222–D226. [PubMed: 25414356] 
33. Gamblin SJ, et al. Activity and specificity of human aldolases. J Mol Biol. 1991; 219:573–576. 
[PubMed: 2056525] 
34. Zhang J, et al. Measuring energy metabolism in cultured cells, including human pluripotent stem 
cells and differentiated cells. Nat Protoc. 2012; 7:1068–1085. [PubMed: 22576106] 
35. Park KS, et al. Transcription elongation factor Tcea3 regulates the pluripotent differentiation 
potential of mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathway. Stem Cells. 2013; 
31:282–292. [PubMed: 23169579] 
36. Ivanova N, et al. Dissecting self-renewal in stem cells with RNA interference. Nature. 2006; 
442:533–538. [PubMed: 16767105] 
Cha et al. Page 17
Nat Cell Biol. Author manuscript; available in PMC 2017 August 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
37. Mu WL, et al. Sox2 deacetylation by Sirt1 is involved in mouse somatic reprogramming. Stem 
Cells. 2015; 33:2135–2147. [PubMed: 25940188] 
38. Miranda KC, et al. A pattern-based method for the identification of MicroRNA binding sites and 
their corresponding heteroduplexes. Cell. 2006; 126:1203–1217. [PubMed: 16990141] 
39. Suh MR, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol. 2004; 
270:488–498. [PubMed: 15183728] 
40. Wang G, et al. Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-
to-epithelial transition and induced pluripotent stem cell generation. Proc Natl Acad Sci USA. 
2013; 110:2858–2863. [PubMed: 23386720] 
41. Gomes P, Outeiro TF, Cavadas C. Emerging role of Sirtuin 2 in the regulation of mammalian 
metabolism. Trends Pharmacol Sci. 2015; 36:756–768. [PubMed: 26538315] 
42. Xiong Y, Guan KL. Mechanistic insights into the regulation of metabolic enzymes by acetylation. J 
Cell Biol. 2012; 198:155–164. [PubMed: 22826120] 
43. Xu Y, et al. Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase. 
Cancer Res. 2014; 74:3630–3642. [PubMed: 24786789] 
44. Hallows WC, Yu W, Denu JM. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by 
Sirt1 protein-mediated deacetylation. J Biol Chem. 2012; 287:3850–3858. [PubMed: 22157007] 
45. Tsusaka T, et al. Deacetylation of phosphoglycerate mutase in its distinct central region by SIRT2 
down-regulates its enzymatic activity. Genes Cells. 2014; 19:766–777. [PubMed: 25195573] 
46. Li T. Glyceraldehyde-3-phosphate dehydrogenase is activated by lysine 254 acetylation in response 
to glucose signal. J Biol Chem. 2014; 289:3775–3785. [PubMed: 24362262] 
47. Somers A, et al. Generation of transgene-free lung disease-specific human induced pluripotent 
stem cells using a single excisable lentiviral stem cell cassette. Stem Cells. 2010; 28:1728–1740. 
[PubMed: 20715179] 
48. Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined 
factors. Cell. 2007; 131:861–872. [PubMed: 18035408] 
49. Kislinger T, et al. Global survey of organ and organelle protein expression in mouse: combined 
proteomic and transcriptomic profiling. Cell. 2006; 125:173–186. [PubMed: 16615898] 
50. Zhou JY, et al. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a 
proteomics approach. J Proteome Res. 2010; 9:5133–5141. [PubMed: 20698585] 
51. Kim D, et al. Generation of human induced pluripotent stem cells by direct delivery of 
reprogramming proteins. Cell Stem Cell. 2009; 4:472–476. [PubMed: 19481515] 
Cha et al. Page 18
Nat Cell Biol. Author manuscript; available in PMC 2017 August 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
SIRT2 downregulation and SIRT1 upregulation is a molecular signature of human 
pluripotency. (a) Immunoprecipitation of hDF and hESCs proteins using antibodies against 
acetyl-Lys, following LC-MS/MS analyses to identify acetylated proteins. Red and blue dots 
represent hyperacetylated proteins in hESCs and in hDFs, respectively. (b) Mean value 
scatter plot of relative expression levels of SIRT1 and SIRT2 in hESC lines (n = 25) and 
normal somatic cell lines (n = 15) using results from a database search (http://
www.nextbio.com). All cell line information is shown in Supplementary Table 5. (Mean ± 
s.e.m., two-tailed unpaired Student’s t-test.) (c) SIRT1 and SIRT2 expression from hDFs, 
iPSCs and hESCs was determined by qRT-PCR. (Mean ± s.e.m., n = 3 biologically 
independent experiments, *P < 0.05; **P < 0.01; ***P < 0.005, one-way ANOVA with 
Newman–Keuls post-test.) (d) Protein levels of SIRT1 and SIRT2. (e) Relative mRNA levels 
of SIRT1, SIRT2, Oct4 and SOX2 during in vitro differentiation of hESCs. (n = 2 
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biologically independent experiments.) (f) Immunofluorescence assays of pluripotency 
markers (Oct4 and Tra-1-60) and neuronal markers (TH and Tuj1) before and after in vitro 
DA differentiation, respectively. Hoechst was used to show nucleus. Scale bar, 100 μm. (g,h) 
Gene expression levels of DA neuronal markers (TH, Lmx1b, and Tuj1) (g) and pluripotency 
markers (h) are shown along with those of SIRT1 and SIRT2. (Mean ± s.e.m., n=3 
biologically independent experiments, *P < 0.05; ***P < 0.005, two-tailed unpaired 
Student’s t-test.) (i) SIRT1 and SIRT2 protein levels during in vitro DA differentiation. 
Statistics source data are in Supplementary Table 9. Unprocessed original scans of blots a,d,i 
are shown in Supplementary Fig. 9.
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Figure 2. 
SIRT2 regulates acetylation and enzymatic activity of glycolytic enzymes. (a) Left: 
representative pictures of inducible SIRT2-GFP H9 hESCs with or without doxycycline 
(Dox). Scale bar, 100 μm. Right: the efficiency of SIRT2 overexpression was confirmed by 
western blotting with SIRT2-specific antibody. (b–d) Total protein extracts from wild-type 
(mock) and inducible SIRT2-GFP hESCs (SIRT2OE) with or without Dox were 
immunoprecipitated with anti-Aldolase A, anti-PGK1, anti-Enolase or anti-GAPDH 
antibodies (b) or anti-acetyl-Lys (c). Acetylation levels of each enzyme were assessed by 
western blotting with an anti-acetyl-Lys antibody (b) or each specific antibody (c). 
Enzymatic activities in each extracts are shown in d. Western blotting of Aldolase A, PGK1, 
Enolase, GAPDH, and β-actin using equal amounts of extracts are shown as the control 
(input). (Mean ± s.d., n=3 biologically independent experiments, ***P < 0.005, two-way 
ANOVA with Bonferroni post-test.) (e) Total proteins from mock and SIRT2OE with or 
without Dox were immunoprecipitated using anti-Aldolase A or anti-Enolase antibodies and 
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western blotting was performed with anti-acetyl-Lys or anti-SIRT2 antibodies. Aldolase A, 
Enolase, and β-actin western blotting of whole cell lysate (Input) from wild-type and SIRT2-
GFP hESCs were used as control of equal protein concentration for the IP. (f,g) Total protein 
extracts from mock and SIRT2 knockdown (KD) hDFs were immunoprecipitated by anti-
Aldolase A, anti-PGK1, anti-Enolase or anti-GAPDH antibodies. Acetylation levels and 
enzyme activity of Aldolase A, PGK1, Enolase or GAPDH were determined by western 
blotting with anti-acetyl-Lys antibody (f) and enzymatic assays (g), respectively. Aldolase A, 
PGK1, Enolase, GAPDH, and β-actin western blotting of whole cell lysate (input) from WT 
and SIRT2KD hDFs were used as control of equal concentration for the IP and enzymatic 
activity assays. (Mean ± s.d. shown. n=3 biologically independent experiments, *P < 0.05, 
two-way ANOVA with Bonferroni post-test.) Statistics source data are in Supplementary 
Table 9. Unprocessed original scans of blots a–c,e,f are shown in Supplementary Fig. 9.
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Figure 3. 
Acetylation status of K322 regulates AldoA activity. (a) Western blotting shows that AldoA-
Myc is highly acetylated in SIRT2KD 293T cells although total proteins are unchanged. (b) 
Sequence alignment of putative acetylation sites (K111 and K322) from different species. (c) 
Myc-tagged AldoA, AldoAK111Q, and AldoAK322Q were each expressed in hDFs. AldoA 
proteins were purified by IP with a Myc antibody, and specific activity for AldoA was 
determined. (Mean ± s.d., n=3 biologically independent experiments, ***P < 0.005, one-way 
ANOVA with Bonferroni post-test.) (d) Myc-tagged AldoA, AldoAK111R, and AldoAK322R 
were each expressed in hDFs co-expressing SIRT2 shRNA (SIRT2KD). AldoA proteins 
were purified by IP with Myc antibody, and specific activity for AldoA was determined. 
(Mean ± s.d., n=3 biologically independent experiments, ***P < 0.005, one-way ANOVA 
with Bonferroni post-test.) (e) Crystal structure model of human AldoA (Protein Data Bank 
code: 1ALD). Statistics source data are in Supplementary Table 9. Unprocessed original 
scans of blots a are shown in Supplementary Fig. 9.
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Figure 4. 
SIRT2 influences metabolism and cell survival of hPSCs. (a) Glycolytic bioenergetics of 
wild-type (mock) and inducible SIRT2-GFP H9 hESCs (SIRT2OE) with or without Dox 
were assessed using the Seahorse XF analyser. Mean ± s.d. shown. n=3 biologically 
independent experiments. (b) Basal glycolytic rate, glycolytic capacity and glycolytic 
reserve from mock and SIRT2OE with or without Dox shown in a. (Mean ± s.d., n=3 
biologically independent experiments, *P < 0.05, one-way ANOVA with Bonferroni post-
test.) (c) Cell proliferation of mock and SIRT2OE H9 hESCs with or without Dox was 
analysed by determining cell numbers every two days under ESC culture condition. (Mean ± 
s.d., n = 3 biologically independent experiments, ***P < 0.005, two-way ANOVA with 
Bonferroni post-test.) (d) GFP-positive (GFP+) WT and SIRT2 H9 hESCs with or without 
Dox were mixed at a ratio of 1:1 with GFP-negative (GFP−) hESCs, respectively. The 
GFP+/GFP− ratios were measured at each passage. (Mean ± s.d., n=3 biologically 
independent experiments, ***P < 0.005, two-way ANOVA with Bonferroni post-test.) (e) 
Apoptotic population of mock and SIRT2OE H9 hESCs with or without Dox for three days 
under ESC culture conditions measured by Annexin V/7-AAD staining. (f) Quantification of 
Cha et al. Page 24
Nat Cell Biol. Author manuscript; available in PMC 2017 August 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Annexin V positive cells in mock and SIRT2OE hESC lines (H9 and H7) and two iPSC lines 
(iPSC-1 and iPSC-2) with or without Dox. 1: Mock w/o Dox, 2: Mock with Dox, 3: 
SIRT2OE w/o Dox, 4: SIRT2OE with Dox. (Mean ± s.d., n=3 biologically independent 
experiments, ***P < 0.005, one-way ANOVA with Bonferroni post-test.) (g) Intracellular 
ROS levels of mock and SIRT2OE hPSCs (H9 and hiPSC-1) with or without Dox. 1: Mock 
w/o Dox, 2: Mock with Dox, 3: SIRT2OE w/o Dox, 4: SIRT2OE with Dox. (Mean ± s.d., n 
= 5 biologically independent experiments, ***P < 0.005, one-way ANOVA with Bonferroni 
post-test.) (h) Effect of antioxidant on cell death of hPSCs (H9 and hiPSC-1) by SIRT2OE 
with or without Dox. 1: Veh only, 2: NAC, 3: Dox+Veh, 4: Dox+NAC. (Mean ± s.d., n=3 
biologically independent experiments, ***P < 0.005, one-way ANOVA with Bonferroni post-
test.) Statistics source data are in Supplementary Table 9.
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Figure 5. 
SIRT2 influences metabolism during early in vitro differentiation of hESCs. (a,b) Inducible 
SIRT2OE H9 hESCs were induced to differentiate spontaneously by culturing in serum-free 
ITSFn medium for up to 4 days, and gene expression levels of pluripotency markers (Oct4, 
Nanog, and Rex1) (a) and early-differentiation markers (Pax6, Brachyury (B-T), and Sox17) 
(b) were determined by qRT-PCR. (Mean ± s.d., n=3 biologically independent 
experiments, *P < 0.05; **P < 0.01, one-way ANOVA with Bonferroni posttest.) (c) 
Expression level of SIRT2 in SIRT2OE H9 hESCs with or without Dox during early 
differentiation. (Mean ± s.d., n=3 biologically independent experiments, *P <0.05, one-way 
ANOVA with Bonferroni posttest.) (d) Glycolytic bioenergetics of mock and SIRT2OE H9 
hESCs with or without Dox were assessed using the Seahorse XF analyser. (Mean ± s.d., 
n=3 biologically independent experiments, *P <0.05, one-way ANOVA with Bonferroni 
post-test.) (e) Extracellular lactate production of mock and SIRT2OE H9 hESCs with or 
without Dox. (Mean ± s.d., n=3 biologically independent experiments, *P < 0.05; **P < 
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0.01; ***P < 0.005, one-way ANOVA with Bonferroni post-test.) (f) SIRT2OE H9 hESCs 
were induced to differentiate spontaneously for 7 days, and differentiating cells were 
immunostained for the presence of lineage-specific markers for ectoderm (Otx2), endoderm 
(Sox17), and mesoderm (B-T). Scale bar, 100 μm. (g) Heatmaps depicting gene expression 
levels of markers representing ectoderm (Pax6, Map2, GFAP and AADC), endoderm 
(Foxa2, Sox17, AFP, CK8 and CK18), and mesoderm (Msx1 and B-T) in wild-type (Mock) 
and inducible SIRT2-GFP (SIRT2OE) H9 and H7 hESC lines with or without Dox 
differentiated for up to 12 days under differentiation condition. 1: Mock w/o Dox, 2: Mock 
with Dox, 3: SIRT2OE w/o Dox, 4: SIRT2OE with Dox. (n=2 biologically independent 
experiments.) Statistics source data are in Supplementary Table 9.
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Figure 6. 
SIRT2KD facilitates metabolic reprogramming in fibroblasts during the induced 
pluripotency. (a,b) Oxygen consumption rate (OCR) (a) and ECAR (b) of human fibroblasts 
(hDFs) infected with control (siNS) or SIRT2 siRNA (siSIRT2) at 3 days after transfection 
were assessed by XF analyser. (Mean ± s.d., n = 3 biologically independent experiments, *P 
<0.05, two-tailed unpaired Student’s t-test.) (c) OXPHOS capacity of hDFs infected with 
siNS or siSIRT2 at 3 days after transfection. (Mean ± s.d., n=3 biologically independent 
experiments.) (d,e) Basal respiration, ATP turnover, maximum respiration, oxidative reserve 
(d) or relative OCR changes after FCCP injection (e) from siNS and siSIRT2 are shown in c. 
(Mean ± s.d., n = 3 biologically independent experiments, **P < 0.01; ***P <0.005, two-
tailed unpaired Student’s t-test.) (f,g) OCR were shown for hDFs infected with lentiviruses 
expressing four reprogramming factors (Y4) and/or SIRT2 knockdown (SIRT2KD) at 3 (f) 
or 8 (g) days after transfection. (Mean ± s.d., n=3 biologically independent experiments.) 
(h,i) Basal respiration, ATP turnover, maximum respiration, and oxidative reserve from Y4 
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and/or SIRT2KD at 3 (h) or 8 (i) days after transfection are shown in f,g. (Mean ± s.d., n=3 
biologically independent experiments, *P <0.05; **P <0.01; ***P <0.005, one-way ANOVA 
with Bonferroni posttest.) (j,k) OCR/ECAR ratio (j) or relative OCR changes after FCCP 
injection (k) from Y4 and/or SIRT2KD are shown in f,g. (Mean ± s.d., n = 3 biologically 
independent experiments, *P <0.05; **P <0.01; ***P <0.005, one-way ANOVA with 
Bonferroni post-test.) Statistics source data are in Supplementary Table 9.
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Figure 7. 
SIRT2 influences somatic nuclear reprogramming through metabolic changes. (a) Time 
course of expression level of SIRT2 mRNA in hDFs infected with Y4 and/or SIRT2KD. 
(Mean ± s.d., n = 4 biologically independent experiments, **P < 0.01; ***P < 0.005, two-way 
ANOVA with Bonferroni post-test.) (b,c) OCR (b) and ECAR (c) in hDFs infected with Y4 
and/or SIRT2KD were assessed by XF analyser. (Mean ± s.d., n=4 biologically independent 
experiments, *P < 0.05; **P < 0.01; ***P <0.005, two-way ANOVA with Bonferroni post-
test.) (d) Measurement of lactate production from hDFs infected with Y4 and/or SIRT2KD. 
(Mean ± s.d., n=3 biologically independent experiments, ***P < 0.005, two-way ANOVA 
with Bonferroni post-test.) (e,f) Effects of SIRT2OE or KD on iPSC generation. Upper: The 
efficiency of overexpression (e) or knockdown (f) was confirmed by western blotting with 
anti-SIRT2 antibody. Lower: Representative pictures of AP-positive colonies at 14 days 
post-infection (dpi). (Mean ± s.e.m., n = 3 biologically independent experiments, **P <0.01, 
two-way ANOVA with Bonferroni post-test.) (g,h) Effects of glycolytic inhibitor, 2-
deoxyglucose (2DG) on iPSC generation by Y4 and/or SIRT2KD at 8 days post-
transduction were assessed by OCR (g) and ECAR (h). (Mean ± s.d., n = 4 biologically 
independent experiments, **P < 0.01; ***P <0.005, two-way ANOVA with Bonferroni post-
test.) (i) Effects of 2DG on iPSC generation by Y4 and/or SIRT2KD. Representative pictures 
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of AP-positive colonies at 14 days post-transduction. (Mean ± s.d., n = 3 biologically 
independent experiments, ***P <0.005, two-way ANOVA with Bonferroni post-test.) 
Statistics source data are in Supplementary Table 9. Unprocessed original scans of blots e,f 
are shown in Supplementary Fig. 9.
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Figure 8. 
miR-200c directly targets SIRT2. (a,b) Altered expression levels of SIRT2 by pre-miRNAs 
were analysed by qRT-PCR (a) or western blotting with SIRT2-specific antibody (b). (Mean 
± s.d., n=3 biologically independent experiments, **P <0.01, one-way ANOVA with 
Bonferroni posttest.) (c) Sequences for stem loop of miR-200c (upper) and matured forms of 
miR-200c-5p and -3p (lower). (d,e) Altered expression levels of SIRT2 by miRNA mimics 
for control (Scr), miR-200c-5p (5p) and -3p (3p) were analysed by qRT-PCR (d) or western 
blotting with SIRT2-specific antibody (e). (Mean ± s.d., n=3 biologically independent 
experiments, ***P <0.005, one-way ANOVA with Bonferroni post-test.) (f) Luciferase 
validation assays demonstrating the effect of miR-200c-5p on the CDS fragments of SIRT2 
relative to control (Scr) in 293T cells. (Mean ± s.d., n = 3 biologically independent 
experiments, **P < 0.01, one-way ANOVA with Bonferroni post-test.) (g) Proposed model 
for miR-200c–SIRT2-glycolytic enzymes (aldolase, GAPDH, enolase, and PGK1) axis in 
regulating metabolic switch and somatic reprogramming. Statistics source data are in 
Supplementary Table 9. Unprocessed original scans of blots b,e are shown in Supplementary 
Fig. 9.
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